Sacubitril Valsartan 100 mg: Uses, Dosage, Benefits & Side Effects
Sacubitril and valsartan tablets are a prescription combination medicine used primarily for the treatment of certain patients with chronic heart failure, particularly heart failure with reduced ejection fraction. SACUSMART 100, marketed by Steris Healthcare, combines sacubitril and valsartan to provide complementary effects on the cardiovascular system.
This medicine may help reduce the workload on the heart, improve blood-vessel relaxation, decrease fluid retention, and lower the risk of hospitalization related to heart failure in appropriate patients. The exact strength and dosage are determined by the healthcare professional according to heart function, blood pressure, kidney function, potassium levels, previous medicines, and individual treatment response.
SACUSMART 100 is not intended to provide immediate relief from acute breathlessness or a sudden heart-failure emergency. Patients experiencing severe shortness of breath, chest pain, fainting, or rapidly worsening swelling require urgent medical assessment.
Why it's important
Heart failure can make it difficult for the heart to pump blood efficiently, potentially causing symptoms such as breathlessness, fatigue, swelling of the legs, and reduced exercise tolerance. Appropriate long-term treatment can help control symptoms and reduce the risk of worsening heart failure.
SACUSMART 100 combines two active components that work through different but complementary pathways. Sacubitril enhances beneficial natriuretic peptide activity, while valsartan blocks the effects of angiotensin II. Together, these actions can reduce excessive blood-vessel constriction and fluid retention while decreasing cardiovascular strain.
Regular monitoring of blood pressure, kidney function, and blood potassium may be required during treatment.
Key Benefits
What are the benefits?
Helps manage chronic heart failure in appropriately selected patients.
May reduce cardiovascular strain and the workload placed on the heart.
Helps promote blood-vessel relaxation.
Can reduce sodium and fluid retention associated with excessive neurohormonal activation.
May reduce the risk of heart-failure-related hospitalization in suitable patients.
Provides dual-action cardiovascular therapy in a single tablet.
May improve symptoms and functional capacity as part of a comprehensive heart-failure treatment plan.
Side Effects
Some people taking SACUSMART 100 may experience side effects. Commonly reported effects can include low blood pressure, dizziness, headache, cough, increased potassium levels, or changes in kidney function.
Dizziness or light-headedness may be more noticeable when treatment is first started or after a dose increase. Patients should stand up slowly and use caution when driving or operating machinery if they feel dizzy.
Blood tests may be recommended because sacubitril and valsartan can affect kidney function and potassium levels. Do not take additional potassium supplements or potassium-containing salt substitutes unless specifically recommended by your healthcare professional.
Serious Side Effects
A potentially serious reaction is angioedema, which may cause sudden swelling of the lips, face, tongue, or throat and difficulty breathing. Seek emergency medical attention if these symptoms occur.
Severe low blood pressure, significant kidney-function deterioration, or dangerously elevated potassium can also occur in susceptible individuals. Symptoms such as fainting, severe weakness, confusion, markedly reduced urine output, or abnormal heart rhythm require prompt medical assessment.
Do not restart the medicine after suspected angioedema unless specifically instructed by an appropriate healthcare professional.
Available Substitute
There is no universal substitute for SACUSMART 100 because treatment selection depends on the type and severity of heart failure, blood pressure, kidney function, potassium level, and previous cardiovascular therapy.
Depending on the clinical situation, a healthcare professional may consider an ACE inhibitor, angiotensin receptor blocker (ARB), beta-blocker, mineralocorticoid receptor antagonist, SGLT2 inhibitor, or another appropriate heart-failure medicine. These medicines are not direct replacements and may have different benefits, risks, and dosing requirements.
Do not switch from sacubitril/valsartan to another cardiovascular medicine without medical guidance.
Dosage Guidelines
Take SACUSMART 100 exactly as prescribed by your healthcare professional. The appropriate starting dose and subsequent dose adjustments depend on factors such as previous ACE inhibitor or ARB use, blood pressure, kidney function, potassium levels, and individual tolerance.
The tablet is generally taken twice daily, according to the prescribed regimen, and should be swallowed with water. It can generally be taken with or without food unless your healthcare professional provides different instructions.
If you miss a dose, take it when remembered unless it is close to the next scheduled dose. Do not take two doses together to compensate for a missed dose.
Do not stop treatment abruptly without consulting your doctor, as continued heart-failure therapy is important for appropriate patients.
Precautions & Warnings
SACUSMART 100 is a prescription heart-failure medicine and should be used under medical supervision. Tell your healthcare professional if you have kidney disease, low blood pressure, high potassium, liver disease, diabetes, or a history of angioedema.
Sacubitril/valsartan must not be taken together with an ACE inhibitor because of the increased risk of angioedema. A suitable interval is required when switching between an ACE inhibitor and sacubitril/valsartan; follow your doctor's specific instructions.
Avoid potassium supplements and potassium-containing salt substitutes unless prescribed. Some other medicines, including potassium-sparing diuretics and certain anti-inflammatory pain medicines, may require additional monitoring.
Sacubitril/valsartan should not be used during pregnancy because medicines acting on the renin-angiotensin system can cause fetal harm. Inform your healthcare professional immediately if pregnancy occurs during treatment.
How to Use Sacubitril and Valsartan Tablets
Take SACUSMART 100 consistently according to the prescribed schedule. Swallow the tablet with water and do not alter, crush, or split it unless the product instructions specifically permit this.
Continue other heart-failure medicines exactly as prescribed unless your healthcare professional changes the treatment plan. Maintain recommended dietary, fluid, physical-activity, and weight-monitoring measures.
Monitor blood pressure when advised and attend scheduled blood tests to assess kidney function and potassium levels. Contact your doctor if you develop persistent dizziness, worsening swelling, significant reduction in urine output, or other concerning symptoms.
Mechanism of Action
Sacubitril and valsartan work through two complementary mechanisms.
Sacubitril is a neprilysin inhibitor. It is converted to its active metabolite, LBQ657, which inhibits neprilysin, an enzyme responsible for breaking down several biologically active peptides, including natriuretic peptides. Increasing natriuretic peptide activity promotes vasodilation, sodium excretion, and reduction of fluid and cardiovascular load.
Valsartan is an angiotensin II receptor blocker (ARB). It selectively blocks the angiotensin II type 1 (AT1) receptor, reducing the effects of angiotensin II, including blood-vessel constriction, sodium retention, and aldosterone-related effects.
By combining neprilysin inhibition with AT1 receptor blockade, sacubitril/valsartan addresses important neurohormonal pathways involved in heart failure. This dual mechanism can help reduce cardiac workload and support improved cardiovascular function in appropriately selected patients.
Conclusion
Sacubitril and valsartan tablets, marketed as SACUSMART 100 by Steris Healthcare, are an important prescription treatment option for appropriate patients with chronic heart failure, particularly heart failure with reduced ejection fraction. Sacubitril enhances beneficial natriuretic peptide activity, while valsartan blocks the harmful effects of angiotensin II. Together, they can help reduce cardiovascular strain, fluid retention, and the risk of heart-failure-related hospitalization in suitable patients. Use SACUSMART 100 exactly as prescribed, attend recommended kidney-function and potassium monitoring, avoid combining it with an ACE inhibitor, and seek urgent care for severe breathlessness, fainting, or facial and throat swelling.
Comments
Post a Comment